Mitsubishi Chemical Group has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a bid to focus on its key chemical businesses. The Japanese chemical company said ...
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it ...
Bain Capital is closing in on its next big target struggling with too much debt – the country’s second-largest hospital operator Healthscope.
The US-based private equity firm and Mitsubishi are finalising details of a transaction that could be announced as soon as ...
BAIN Capital is nearing a deal to buy Mitsubishi Chemical Group’s pharmaceutical unit, sources familiar with the matter said, ...
McKinsey & Co. partners have been questioning the consulting giant’s presence in China, worried that doing business there may ...
Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...
Ken Griffin’s hedge fund is taking a fraction of the space in its exit from Citadel Center; TPG Angelo Gordon negotiating ...
The Miami-based hedge fund is poised to slash the size of its local workspace and move it to River North. But another firm is ...
The top firms supporting the energy and utilities industries include consulting giants McKinsey, BCG, Bain & Co and Arthur D.
Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback